Your browser doesn't support javascript.
loading
Continuous glucose monitoring and Rituximab treatment in insulin autoimmune syndrome.
Boro, Hiya; Gupta, Uttio; Singh, Charandeep; Malhotra, Rakhi; Khadgawat, Rajesh.
Affiliation
  • Boro H; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Electronic address: hiya21288@gmail.com.
  • Gupta U; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Singh C; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Malhotra R; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Khadgawat R; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Diabetes Metab Syndr ; 15(6): 102294, 2021.
Article in En | MEDLINE | ID: mdl-34562871

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Autoimmune Diseases / Blood Glucose / Blood Glucose Self-Monitoring / Rituximab / Hyperinsulinism / Immunologic Factors / Insulin Antibodies Limits: Female / Humans / Middle aged Language: En Journal: Diabetes Metab Syndr Year: 2021 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Autoimmune Diseases / Blood Glucose / Blood Glucose Self-Monitoring / Rituximab / Hyperinsulinism / Immunologic Factors / Insulin Antibodies Limits: Female / Humans / Middle aged Language: En Journal: Diabetes Metab Syndr Year: 2021 Document type: Article Country of publication: